spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Medinol 

 HSMN NewsFeed - 7 Oct 2024
Medinol Announces Successful First-in-Human Implantation of ChampioNIR Drug-Eluting Peripheral Stent System in Australia
Devices Interventional
 HSMN NewsFeed - 30 Nov 2017
Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 14 Jan 2014
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme(TM) Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Dec 2010
OrbusNeich Issues Statement on Boston Scientific's Unsuccessful Retaliatory Litigation Efforts in the Netherlands
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 Mar 2010
Cordis Unveils Next Generation CoCr Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Sep 2009
Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 19 Mar 2009
Olympus Medical Systems in Collaboration with Medinol Ltd. Announces the Release of the X-Suit NIR(R), a Biliary Metallic Stent Featuring Exceptional Anatomic Conformability
Devices Interventional
 HSMN NewsFeed - 1 Oct 2008
Boston Scientific Announces Court Decision
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 15 Sep 2008
Boston Scientific Announces Court Decision
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 13 May 2008
State-of-the-Art Cobalt Chromium Bare Metal Stent Now Available in Europe
Devices Interventional Cardiology
 HSMN NewsFeed - 12 May 2008
Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Nov 2007
ARIAD Expands Leadership Team with Three New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2007
ARIAD Announces Collaboration with ICON Medical to Develop and Commercialize Novel Deforolimus-Eluting Stents
Devices Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 2 Oct 2007
ARIAD Names Vice President, Clinical Operations to Further Enhance Global Clinical Development Efforts
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Sep 2007
ARIAD Initiates Phase 3 'Succeed' Trial of Oral Deforolimus in Patients with Metastatic Sarcomas
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Sep 2007
ARIAD Announces Agreement with FDA on Special Protocol Assessment for Phase 3 Clinical Trial of Oral Deforolimus
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Aug 2007
Deforolimus Approved as Nonproprietary Name for AP23573 - ARIAD's Novel mTOR Inhibitor
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Jul 2007
ARIAD and Merck & Co., Inc. Announce Global Collaboration to Jointly Develop and Commercialize AP23573 - ARIAD's Novel mTOR Inhibitor - for Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jun 2007
ARIAD Announces Appointment of Senior Oncology Executive to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2007
ARIAD Presents Additional Efficacy Data on AP23573, Novel mTOR Inhibitor, in Phase 2 Advanced Sarcoma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 May 2007
Cordis Corporation Signs Definitive Agreement with Medinol for Global Distribution of Bare Metal Stents
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 14 Apr 2007
ARIAD files claim against Amgen and Wyeth Alleging Infringement of NF-(kappa)B Patent by Enbrel(R) and Kineret(R)
Biopharmaceuticals Litigation
 HSMN NewsFeed - 12 Feb 2007
ARIAD Grants Second Commercial License to Its Patented ARGENT(TM) Cell-Signaling Regulation Technology for Development of New Cancer Therapies
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 2 Nov 2006
ARIAD Presents Expanded Efficacy Data On AP23573, Novel mTOR Inhibitor, In Phase 2 Advanced Sarcoma Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Oct 2006
ARIAD Grants Commercial License to Its Patented ARGENT(TM) Cell-Signaling Regulation Technology for Development of New Cancer Therapies
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Sep 2006
ARIAD Announces Update Regarding NF-(kappa)B Patent Lawsuit with Amgen
Biopharmaceuticals Litigation
 HSMN NewsFeed - 4 May 2006
Jury Rules in Favor of ARIAD and Co-Plaintiffs in Lilly NF-(kappa)B Patent Infringement Lawsuit
Biopharmaceuticals Litigation
Return to NewsFeed  

 Additional items found! 27

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 27 additional stories matching:
Medinol
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.